IL-15 Amplifies the Pathogenic Properties of CD4+CD28− T Cells in Multiple Sclerosis
- 1 March 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 194 (5) , 2099-2109
Abstract
CD4+CD28− T cells arise through repeated antigenic stimulation and are present in diseased tissues of patients with various autoimmune disorders, including multiple sclerosis (MS). These cells are believed to have cytotoxic properties that contribute to the pathogenic damaging of the target organ. Endogenous cues that are increased in the diseased tissue may amplify the activity of CD4+CD28− T cells. In this study, we focused on IL-15, a cytotoxicity-promoting cytokine that is increased in the serum and cerebrospinal fluid of MS patients. Using immunohistochemistry, we demonstrate that IL-15 is mainly produced by astrocytes and infiltrating macrophages in inflammatory lesions of MS patients. Moreover, in vitro transmigration studies reveal that IL-15 selectively attracts CD4+CD28− T cells of MS patients, but not of healthy individuals. IL-15 further induces the expression of chemokine receptors and adhesion molecules on CD4+CD28− T cells, as investigated using flow cytometry, resulting in enhanced migration over a monolayer of human brain endothelial cells. Finally, flow cytometric analyses revealed that IL-15 increases the proliferation and production of GM-CSF, expression of cytotoxic molecules (NKG2D, perforin, and granzyme B), and degranulation capacity of CD4+CD28− T cells. Taken together, these findings indicate that increased peripheral and local levels of IL-15 amplify the pathogenic potential of CD4+CD28− T cells, thus contributing to tissue damage in MS brain lesions.Keywords
This publication has 55 references indexed in Scilit:
- CX3CR1 drives cytotoxic CD4+CD28− T cells into the brain of multiple sclerosis patientsJournal of Autoimmunity, 2012
- The CD4+ T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosisJournal of Neuroimmunology, 2012
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisNature, 2011
- IL‐15 preferentially enhances functional properties and antigen‐specific responses of CD4+CD28null compared to CD4+CD28+ T cellsAging Cell, 2011
- Contribution of Astrocyte-Derived IL-15 to CD8 T Cell Effector Functions in Multiple SclerosisThe Journal of Immunology, 2010
- Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 2010
- CD56bright natural killer (NK) cells: an important NK cell subsetImmunology, 2009
- Interleukin‐15 stimulates macrophages to activate CD4+T cells: a role in the pathogenesis of rheumatoid arthritis?Immunology, 2008
- Membrane bound IL-15 is increased on CD14 monocytes in early stages of MSJournal of Neuroimmunology, 2008
- Multiple sclerosis: a complicated picture of autoimmunityNature Immunology, 2007